DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 01 · Volume 47 · January 2014 DOI: 10.1055/s-004-26284

Review

  • 1
    La Torre, A.; Giupponi, G.; Duffy, D. M.; Pompili, M.; Grözinger, M.; Kapfhammer, H. P.; Conca, A.:

    Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review. Part III: Mood Stabilizers and Anxiolytic Drugs

  • 7
    Soyka, M.:

    Opioids and Traffic Safety – Focus on Buprenorphine

    • Original Paper

  • 18
    Kamat, M. A.; Edgar, L.; Niblock, P.; McDowell, C.; Kelly, C. B.:

    Association between Antidepressant Prescribing and Suicide Rates in OECD Countries: An Ecological Study

  • 22
    Ott, R.; Biller-Andorno, N.:

    Neuroenhancement among Swiss Students – A Comparison of Users and Non-Users

  • 29
    Schwarz, V.; Reis, O.; Glaser, T.; Thome, J.; Hiemke, C.; Haessler, F.:

    Therapeutic Drug Monitoring of Zuclopenthixol in a Double-Blind Placebo-Controlled Discontinuation Study in Adults with Intellectual Disabilities and Aggressive Behaviour

    • Letter

  • 33
    Verde, Z.; Santiago, C.; Rodríguez González-Moro, JM.; de Lucas Ramos, P.; López Martín, S.; Bandrés, F.; Lucia, A.; Gómez-Gallego, F.:

    Are Serotonergic System Genes Associated to Smoking Cessation Therapy Success in Addition to CYP2A6?

  • 36
    Bonnet, U.; Khalil-Boutros, Y.:

    Acute Bilateral Parotitis Occurring during Venlafaxine Titration in an Adolescent Female with Major Depression